Disclosures for "Association of Frailty and Survival After Treatment in Older Patients with Glioblastoma"
-
Dr. Hardy has received research support from the American Cancer Society.
-
Ms. Strawderman has nothing to disclose.
-
Dr. Hemminger has nothing to disclose.
-
Dr. Janelsins has nothing to disclose.
-
Miss Cawley has nothing to disclose.
-
Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
-
Mrs. Behr has nothing to disclose.
-
Dr. Milano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Milano has received publishing royalties from a publication relating to health care.
-
Dr. Magnuson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Clinical Oncology Cancer.ent. The institution of Dr. Magnuson has received research support from National Institute of Health.
-
Dr. Mohile has nothing to disclose.